Judge Orders Pentagon to Clarify Testosterone Policy Amid Transgender Military Ban Challenge
A federal judge has mandated the Pentagon to justify its policy on testosterone treatment, which is being promoted as a readiness benefit for some service members, while simultaneously being used to exclude transgender troops from the military. U.S. District Judge Ana Reyes has ordered both parties in the case challenging President Trump's transgender military ban to address Defense Secretary Pete Hegseth's new testosterone screening and treatment program. This program, announced on July 15, involves annual screenings for testosterone deficiency for service members aged 30 and older, with voluntary testosterone replacement therapy (TRT) available. The judge's order highlights a contradiction in the administration's stance, as the same hormone treatment is used to justify the exclusion of transgender troops. The court has set an August 7 deadline for briefing on this issue, as the case progresses towards trial. 
